Parkinson's Hero Image

A disorder that mainly targets the dopamine-producing neurons in the brain, causing tremors, rigidity, balance issues and cognitive changes.



Doug Williamson Thumbnail

There Are No Failures in Parkinson’s Research; Only Setbacks

Parkinson’s disease can’t be slowed or cured, but researchers like Dr. Williamson are working to change that.

Rich Clifford Thumbnail

Parkinson’s disease does not mean living with limits

Thanks to Parkinson’s Disease research and treatment advances, astronaut Rich Clifford continues to live his life without limitations.

Researcher Profile: Ian Reynolds image

Researcher Profile: Ian Reynolds

Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).

Cellular Pioneering: Dr. Jeffrey Conn

Cellular Pioneering: Dr. Jeffrey Conn

A pioneer in mental health research, Dr. Jeffrey Conn works to advance treatments for neurological and psychiatric disorders, such as schizophrenia and Parkinson's disease.

Researcher Profile: Pablo Sardi image

Researcher Profile: Pablo Sardi

Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He started his career in Boston doing post-doctoral research at Harvard and moved to Genzyme in 2007 to pursue his interest in investigating disease mechanism to develop therapies to treat neurodegenerative diseases.

Researcher Profile: Darryle Schoepp image

Researcher Profile: Darryle Schoepp

Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.